CATALYST BIOSCIENCES, INC. Modification Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Contingent Value Rights Agreement between Catalyst Biosciences, Inc. and American Stock Transfer & Trust Company, LLC
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2023
Agreement and Amendment to Asset Purchase Agreement between Catalyst Biosciences, Inc. and GNI Group Ltd.
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2023
Amendment to Business Combination Agreement among Catalyst Biosciences, GNI Entities, Minority Holders, and Continent Pharmaceuticals Inc.
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2023
Letter Agreement Regarding Discontinuation of Inversine® and Royalty Payments between Targacept, Inc. and Merck & Co., Inc.
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2009
Amendment Letter to Collaborative Research and License Agreements between Targacept, Inc. and Aventis Pharma SA
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2006
Amendment Letter to Collaborative Research and License Agreements between Targacept, Inc. and Aventis Pharma SA (March 18, 2003)
Modification Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
2004